Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Mandelboim

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Cellular and Molecular Life Sciences : CMLS|May 2, 2012
Virus-mediated inhibition of natural cytotoxicity receptor recognitionEinat Seidel, Ariella Glasner, Ofer Mandelboim
Oncoimmunology|March 13, 2013
Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptorPinchas Tsukerman, Jonatan Enk, Ofer Mandelboim
Human Antibodies|December 31, 2016
The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodiesNatan Stein, Pinchas Tsukerman, Ofer Mandelboim
Journal of Virology|June 6, 2008
Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteinsHagit Achdout, Irit Manaster, Ofer Mandelboim
Scientific Reports|January 31, 2017
Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)Ariella Glasner, Batya Isaacson, Ofer Mandelboim
Periodontology 2000|March 4, 2022
Fusobacterium nucleatum and cancerTamar Alon-Maimon, Ofer Mandelboim, Gilad Bachrach
Journal for Immunotherapy of Cancer|July 4, 2020
Molecular mechanisms of human herpes viruses inferring with host immune surveillanceSimon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
Seminars in Cancer Biology|August 9, 2006
Tumor and viral recognition by natural killer cells receptorsTal I Arnon, Gal Markel, Ofer Mandelboim
Journal of the National Cancer Institute|September 14, 2014
The role of microRNAs in the control of innate immune response in cancerSimon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
The Journal of Urology|October 20, 2007
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot studyVladimir Yutkin, Dov Pode, Eli Pikarsky, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Cellular and Molecular Life Sciences : CMLS|May 2, 2012
Virus-mediated inhibition of natural cytotoxicity receptor recognitionEinat Seidel, Ariella Glasner, Ofer Mandelboim
Oncoimmunology|March 13, 2013
Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptorPinchas Tsukerman, Jonatan Enk, Ofer Mandelboim
Human Antibodies|December 31, 2016
The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodiesNatan Stein, Pinchas Tsukerman, Ofer Mandelboim
Journal of Virology|June 6, 2008
Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteinsHagit Achdout, Irit Manaster, Ofer Mandelboim
Scientific Reports|January 31, 2017
Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)Ariella Glasner, Batya Isaacson, Ofer Mandelboim
Periodontology 2000|March 4, 2022
Fusobacterium nucleatum and cancerTamar Alon-Maimon, Ofer Mandelboim, Gilad Bachrach
Journal for Immunotherapy of Cancer|July 4, 2020
Molecular mechanisms of human herpes viruses inferring with host immune surveillanceSimon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
Seminars in Cancer Biology|August 9, 2006
Tumor and viral recognition by natural killer cells receptorsTal I Arnon, Gal Markel, Ofer Mandelboim
Journal of the National Cancer Institute|September 14, 2014
The role of microRNAs in the control of innate immune response in cancerSimon Jasinski-Bergner, Ofer Mandelboim, Barbara Seliger
The Journal of Urology|October 20, 2007
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot studyVladimir Yutkin, Dov Pode, Eli Pikarsky, et al.
Pageof 24